Finance

Lists
Why is FMCQF down ४.३५%?
Dive Deeper
FMCQF:OTCMKTS
Fresenius Medical Care AG
US$ ४२.३७
-४.३५%
(-१.९३) 1D
अक्टोबर ७, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FMCQF...
Open
US$ ४२.३७
High
US$ ४२.३७
Low
US$ ४२.३७
Mkt. cap
११.३० अरब
Avg. vol.
१५८.००
Volume
०.००
52-wk high
US$ ५६.२४
52-wk low
US$ ४२.००
Beta
०.८१
Shares outstanding
२६.८६ करोड
No. of employees
१ लाख
Open
US$ ४२.३७
High
US$ ४२.३७
Low
US$ ४२.३७
Mkt. cap
११.३० अरब
Avg. vol.
१५८.००
Volume
०.००
52-wk high
US$ ५६.२४
52-wk low
US$ ४२.००
Beta
०.८१
Shares outstanding
२६.८६ करोड
No. of employees
१ लाख
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
८ घण्टा पहिले
Fresenius Medical Care replaces CEO, stock under pressure
Yahoo Finance
Yahoo Finance
·
१० घण्टा पहिले
Fresenius Medical Care names Korangy as new chief executive
GuruFocus
GuruFocus
·
१९ घण्टा पहिले
Fresenius Medical Care AG (FMS) Shares Fall 7.7% -- What GF Scor
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOHelen Giza
Employees१.०७ लाख
Founded१९९६
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.८८ अरब
५.०७ अरब
४.६१ अरब
४.८६ अरब
Cost of goods sold
३.६४ अरब
३.६८ अरब
३.४३ अरब
३.५५ अरब
Cost of revenue
३.६४ अरब
३.६८ अरब
३.४३ अरब
३.५५ अरब
Research and development expenses
३.७७ करोड
३.८६ करोड
३.८३ करोड
३.९६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७०.५४ करोड
७८.४६ करोड
७४.८९ करोड
७३.६० करोड
Operating expense
७४.०५ करोड
७९.६३ करोड
८०.३९ करोड
७८.६४ करोड
Total operating expenses
४.३८ अरब
४.४८ अरब
४.२४ अरब
४.३४ अरब
Operating income
५०.१७ करोड
५९.२० करोड
३७.५६ करोड
५२.३६ करोड
Other non operating income
-
-
-
-
EBT including unusual items
४०.२६ करोड
५०.८५ करोड
२०.७५ करोड
३८.३० करोड
EBT excluding unusual items
४६.२७ करोड
५४.१८ करोड
३३.४४ करोड
३९.९२ करोड
Income tax expense
७.५२ करोड
१०.६४ करोड
४.२८ करोड
८.९८ करोड
Effective tax rate
१८.६९%
२०.९३%
२०.६०%
२३.४५%
Other operating expenses
-२६.८९ लाख
-२.६९ करोड
१.६७ करोड
१.०७ करोड
Net income
२७.४८ करोड
३२.७१ करोड
११.७५ करोड
२१.८४ करोड
Net profit margin
५.६३%
६.४५%
२.५५%
४.४९%
Earnings per share
१.१०
१.४४
०.९१
०.५६
Interest and investment income
१.९२ करोड
१.३६ करोड
१.४६ करोड
१.४७ करोड
Interest expense
-९.३१ करोड
-९.९० करोड
-९.३३ करोड
-९.७६ करोड
Net interest expenses
-७.३९ करोड
-८.५४ करोड
-७.८७ करोड
-८.२९ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
८५.३६ करोड
७८.०२ करोड
७२.७८ करोड
८७.९४ करोड
Gain or loss from assets sale
५.०३ करोड
१.७९ करोड
८७.७१ लाख
-४०.९४ लाख
AI content may include mistakes. Learn more
Google एपहरू